Comparison of skin prick test with serially diluted wild-type and genetically engineered recombinant Der f2
- 31 March 2000
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 84 (3) , 366-368
- https://doi.org/10.1016/s1081-1206(10)62788-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Immunotherapy of allergy: anergy, deletion, and immune deviationCurrent Opinion in Immunology, 1998
- Allergen Immunotherapy: Therapeutic Vaccines for Allergic DiseasesAnnals of Allergy, Asthma & Immunology, 1998
- Hyposensitization to allergic reaction in rDer f 2-sensitized mice by the intranasal administration of a mutant of rDer f 2, C8/119SClinical and Experimental Immunology, 1998
- Recombinant allergensAllergy, 1998
- Risk and safety of immunotherapyAllergy, 1998
- Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapyNature Biotechnology, 1997
- Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy.Journal of Clinical Investigation, 1997
- IgE Responsiveness to Dermatophagoides farinae in Young Asthmatic Children: IgE Binding Study Using Recombinant Allergens of Der f 1, Der f 2 and Mutant Proteins of Der f 2International Archives of Allergy and Immunology, 1996
- Antigenic and structural analysis of group II allergens (Der f II and Der p II) from house dust mites (Dermatophagoides spp)Journal of Allergy and Clinical Immunology, 1989